Skip to main content

Table 2 Clinical characteristics of the participants

From: Inequality in uptake of isoniazid prevention therapy and Mantoux test among pregnant women with HIV in the Eastern Cape, South Africa

Variables (N = 1709)

Frequency

Percent

Trimester at booking

 First

210

12.3

 Second

1229

71.9

 Third

270

15.8

Status at first antenatal booking

 Positive

1382

80.9

 Negative

94

5.5

 Unknown

233

13.6

On HAART at Booking

 Yes

998

58.4

 No

711

41.6

WHO Clinical Stage

 Stage I

1500

87.8

 Stage II

189

11.1

 Stage III

16

0.9

 Stage IV

4

0.2

CD4 at booking

 500 and above

478

28.0

 200–499

733

42.9

 Unknown

279

16.3

 Less than 200

219

12.8

Viral load at booking

 Undetectable (< 50)

636

37.2

 Low viremia (50–999)

185

10.8

 Unknown

654

38.3

 High viremia (≥1000)

234

13.7

  1. SD Standard deviation, HAART Highly active anti-retroviral therapy, WHO World Health Organization